SCHEMBL14720525

SCHEMBL14720525

COC1CC(=O)N(Cc2ccc(C=C3CCN(C4CCC4)CC3)cc2)C1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 7/20 0.35
PDE4B Q07343 5/20 0.35
PDE4C Q08493 5/20 0.35
PDE4D Q08499 5/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
PER2 O15055 1/20 0.34
CRY2 Q49AN0 1/20 0.34
ALDH1A1 P00352 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK1 P28482 1/20 0.33
ALOX15 P16050 1/20 0.33
SRD5A2 P31213 1/20 0.33
FKBP1A P62942 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14720524 1.00 PDE4A (0.35) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL14731049 0.82 PER2 (0.38) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL14720876 0.81 FKBP1A (0.38) PER2CRY2SRD5A2FKBP1A
SCHEMBL14720875 0.81 FKBP1A (0.38) PER2CRY2SRD5A2FKBP1A
SCHEMBL14720643 0.81 OPRM1 (0.41) SMN1; SMN2L3MBTL1
SCHEMBL14720463 0.80 L3MBTL1 (0.47) ALDH1A1L3MBTL1MAPK1SRD5A2CYP2C9
SCHEMBL14721179 0.80 L3MBTL1 (0.50) L3MBTL1SRD5A2CYP2D6CYP2C9
SCHEMBL14720649 0.78 FKBP1A (0.35) SMN1; SMN2ALDH1A1L3MBTL1SRD5A2FKBP1A
SCHEMBL14721980 0.76 HRH3 (0.43) SMN1; SMN2L3MBTL1SRD5A2
SCHEMBL14720854 0.76 HRH3 (0.40) L3MBTL1SRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed